Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription


1 Am J Hematol
1 Blood
5 BMC Cancer
1 Cancer Chemother Pharmacol
1 Cancer Res
1 Cell
3 Eur J Haematol
1 Exp Cell Res
1 Int J Hematol
2 Leuk Lymphoma
11 Leukemia
1 N Engl J Med
1 Semin Oncol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Hematol

  1. PRESS RD, Eickelberg G, Froman A, Yang F, et al
    NGS-Defined Minimal Residual Disease Before Stem Cell Transplantation Predicts Acute Myeloid Leukemia Relapse.
    Am J Hematol. 2019 May 23. doi: 10.1002/ajh.25514.
    PubMed     Text format     Abstract available


    RETRACTION: Dasmahapatra G, Rahmani M, Dent P, Grant S. The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood. 2006
    Blood. 2019 May 24. pii: blood-2019-05-901215. doi: 10.1182/blood-2019-05-901215
    PubMed     Text format    

    BMC Cancer

  3. LI L, Liu C, Cai X, Yu H, et al
    Validity and reliability of the EQ-5D-5 L in family caregivers of leukemia patients.
    BMC Cancer. 2019;19:522.
    PubMed     Text format     Abstract available

  4. SUZUKI S, Kofune H, Uozumi K, Yoshimitsu M, et al
    A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma.
    BMC Cancer. 2019;19:516.
    PubMed     Text format     Abstract available

  5. MOSQUERA ORGUEIRA A, Antelo Rodriguez B, Alonso Vence N, Diaz Arias JA, et al
    The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution.
    BMC Cancer. 2019;19:515.
    PubMed     Text format     Abstract available

  6. BHAT GR, Bhat A, Verma S, Sethi I, et al
    Association of newly identified genetic variant rs2853677 of TERT with non-small cell lung cancer and leukemia in population of Jammu and Kashmir, India.
    BMC Cancer. 2019;19:493.
    PubMed     Text format     Abstract available

  7. JIN M, Hu Y, Wu W, Luo Y, et al
    Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report.
    BMC Cancer. 2019;19:486.
    PubMed     Text format     Abstract available

    Cancer Chemother Pharmacol

  8. NOBRE CF, Newman MJ, DeLisa A, Newman P, et al
    Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations.
    Cancer Chemother Pharmacol. 2019 May 27. pii: 10.1007/s00280-019-03875.
    PubMed     Text format     Abstract available

    Cancer Res

  9. RABE JL, Gardner L, Hunter R, Fonseca JA, et al
    IL-12 abrogates calcineurin-dependent immune evasion during leukemia progression.
    Cancer Res. 2019 May 29. pii: 0008-5472.CAN-18-3800.
    PubMed     Text format     Abstract available


  10. BARYAWNO N, Przybylski D, Kowalczyk MS, Kfoury Y, et al
    A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia.
    Cell. 2019 May 9. pii: S0092-8674(19)30459-3. doi: 10.1016/j.cell.2019.
    PubMed     Text format     Abstract available

    Eur J Haematol

  11. SAKAROU M, Eisele L, Duhrsen U, Huttmann A, et al
    Efficacy of the GMALL-B-ALL/NHL2002 Protocol in Burkitt Leukaemia/Lymphoma and Aggressive Non-Hodgkin-Lymphomas with or without CNS-Involvement.
    Eur J Haematol. 2018 Nov 24. doi: 10.1111/ejh.13199.
    PubMed     Text format     Abstract available

  12. HAMMRICH J, Wittig S, Ernst T, Gruhn B, et al
    CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood.
    Eur J Haematol. 2019;102:251-255.
    PubMed     Text format     Abstract available

  13. WARNY M, Helby J, Sengelov H, Nordestgaard BG, et al
    Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high-risk myelodysplastic syndrome.
    Eur J Haematol. 2019;102:218-226.
    PubMed     Text format     Abstract available

    Exp Cell Res

  14. WANG MM, Zhuang LK, Zhang YT, Xia D, et al
    A novel specific cleavage of IkappaBalpha protein in acute myeloid leukemia cells involves protease PR3.
    Exp Cell Res. 2019 May 21. pii: S0014-4827(19)30263.
    PubMed     Text format     Abstract available

    Int J Hematol

  15. MITANI Y, Hiwatari M, Seki M, Hangai M, et al
    Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions.
    Int J Hematol. 2019 May 27. pii: 10.1007/s12185-019-02665.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  16. BODDU P, Jain P, Borthakur G, Verstovsek S, et al
    Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy.
    Leuk Lymphoma. 2019 May 24:1-9. doi: 10.1080/10428194.2019.1617862.
    PubMed     Text format     Abstract available

  17. ZAJAC-SPYCHALA O, Skalska-Sadowska J, Wachowiak J, Szmydki-Baran A, et al
    Infections in children with acute myeloid leukemia: increased mortality in relapsed/refractory patients.
    Leuk Lymphoma. 2019 May 28:1-8. doi: 10.1080/10428194.2019.1616185.
    PubMed     Text format     Abstract available


  18. SHIMONI A, Labopin M, Lorentino F, Van Lint MT, et al
    Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.
    Leukemia. 2019;33:230-239.
    PubMed     Text format     Abstract available

  19. FRASZCZAK J, Vadnais C, Rashkovan M, Ross J, et al
    Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice.
    Leukemia. 2019;33:110-121.
    PubMed     Text format     Abstract available

  20. SCHNEIDT V, Ilecka M, Dreger P, van Zyl DG, et al
    Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo.
    Leukemia. 2019;33:88-98.
    PubMed     Text format     Abstract available

  21. ARAKI M, Yang Y, Imai M, Mizukami Y, et al
    Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation.
    Leukemia. 2019;33:122-131.
    PubMed     Text format     Abstract available

  22. HAUBNER S, Perna F, Kohnke T, Schmidt C, et al
    Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML.
    Leukemia. 2019;33:64-74.
    PubMed     Text format     Abstract available

  23. DWIVEDI P, Muench DE, Wagner M, Azam M, et al
    Time resolved quantitative phospho-tyrosine analysis reveals Bruton's Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors.
    Leukemia. 2019;33:75-87.
    PubMed     Text format     Abstract available

  24. NIYONGERE S, Lucas N, Zhou JM, Sansil S, et al
    Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML.
    Leukemia. 2019;33:205-216.
    PubMed     Text format     Abstract available

  25. HOUSHMAND M, Simonetti G, Circosta P, Gaidano V, et al
    Chronic myeloid leukemia stem cells.
    Leukemia. 2019 May 24. pii: 10.1038/s41375-019-0490.
    PubMed     Text format     Abstract available

  26. NII T, Prabhu VV, Ruvolo V, Madhukar N, et al
    Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia.
    Leukemia. 2019 May 24. pii: 10.1038/s41375-019-0491.
    PubMed     Text format     Abstract available

  27. ARMENTEROS-MONTERROSO E, Zhao L, Gasparoli L, Brooks T, et al
    The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia.
    Leukemia. 2019 May 28. pii: 10.1038/s41375-019-0495.
    PubMed     Text format     Abstract available

  28. TACHIBANA T, Kanda J, Ishizaki T, Najima Y, et al
    Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis.
    Leukemia. 2019 May 30. pii: 10.1038/s41375-019-0494.
    PubMed     Text format     Abstract available

    N Engl J Med

    Count Your Blessings.
    N Engl J Med. 2019;380:1690-1693.
    PubMed     Text format    

    Semin Oncol

  30. HUSSAIN L, Maimaitiyiming Y, Islam K, Naranmandura H, et al
    Acute promyelocytic leukemia and variant fusion proteins: PLZF-RARalpha fusion protein at a glance.
    Semin Oncol. 2019 May 7. pii: S0093-7754(18)30183.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.